PROCEPT BioRobotics Corporation
PRCT
$40.52
$1.213.08%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 14.49% | 1.36% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 14.49% | 1.36% | |||
| Cost of Revenue | 9.74% | 1.78% | |||
| Gross Profit | 17.18% | 1.12% | |||
| SG&A Expenses | 2.00% | 14.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.94% | 9.84% | |||
| Operating Income | 19.13% | -39.21% | |||
| Income Before Tax | 20.86% | -31.19% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 20.86% | -31.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 20.86% | -31.19% | |||
| EBIT | 19.13% | -39.21% | |||
| EBITDA | 20.65% | -42.21% | |||
| EPS Basic | 21.60% | -28.61% | |||
| Normalized Basic EPS | 21.60% | -28.60% | |||
| EPS Diluted | 21.60% | -28.61% | |||
| Normalized Diluted EPS | 21.60% | -28.60% | |||
| Average Basic Shares Outstanding | 0.96% | 2.00% | |||
| Average Diluted Shares Outstanding | 0.96% | 2.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||